The International Quotidian Dialysis Registry: Annual report 2008

Alternative hemodialysis (HD) schedules, including short‐daily and nocturnal HD, continue to proliferate, with the hope of offering improved patient outcomes. Three nights per week and every other night, nocturnal HD are now being provided to more patients worldwide, both at home and in‐center. Howe...

Full description

Saved in:
Bibliographic Details
Published in:Hemodialysis international 2008-07, Vol.12 (3), p.281-289
Main Authors: NESRALLAH, Gihad E., SURI, Rita S., MOIST, Louise M., OFSTHUN, Norma J., HAKIM, Raymond, MCDONALD, Stephen P., MARSHALL, Mark R., CARTER, Shannon T., LINDSAY, Robert M.
Format: Article
Language:English
Subjects:
Adult
Aged
daily dialysis
dialysis outcomes
Female
Humans
International Cooperation
Kidney Failure, Chronic - epidemiology
Kidney Failure, Chronic - therapy
Male
Middle Aged
nocturnal dialysis
Quotidian hemodialysis
Registries - statistics & numerical data
registry
Renal Dialysis - statistics & numerical data
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Alternative hemodialysis (HD) schedules, including short‐daily and nocturnal HD, continue to proliferate, with the hope of offering improved patient outcomes. Three nights per week and every other night, nocturnal HD are now being provided to more patients worldwide, both at home and in‐center. However, alternative HD schedules are still experimental in most centers, and studies establishing the efficacy of these therapies with respect to major clinical outcomes are needed. Endorsed by the National Institutes of Health, the International Quotidian Dialysis Registry is an international collaboration that was established in 2002 to prospectively study large numbers of patients treated with alternate HD schedules. The Registry will ultimately allow alternate HD modalities to be compared to conventional thrice‐weekly HD with respect to clinical endpoints, including mortality, using a prospective cohort study. To date, the Registry has enrolled 182, 1193, and 740 subjects from Canada, the United States, and Australia, respectively. This report is the fourth annual update and describes recruitment progress, baseline characteristics of enrolled patients, and worldwide prescription patterns.
ISSN:1492-7535
1542-4758
DOI:10.1111/j.1542-4758.2008.00268.x